Global EditionASIA 中文雙語Fran?ais
    World
    Home / World / Asia-Pacific

    Japan gears up to begin clinical tests for vaccine

    By WANG XU | China Daily | Updated: 2020-06-19 13:44
    Share
    Share - WeChat
    A medical worker conducts a simulation for a walk-in style polymerase chain reaction (PCR) test for the coronavirus disease (COVID-19), at a makeshift facility in Yokosuka, south of Tokyo, Japan, April 23, 2020. [Photo/Agencies]

    Japan hopes to conduct clinical tests of a vaccine for the novel coronavirus by the end of June, local media reported, hoping it will be available to the general public as early as spring next year.

    According to Osaka Governor Hirofumi Yoshimura, the test will initially target 20 to 30 medical workers at Osaka City University Hospital, and is expected to expand to hundreds by October.

    "I think it will be the first clinical test (of a coronavirus vaccine) on humans in Japan," Yoshimura said.

    Starting from April, the prefectural and municipal governments of Osaka as well as AnGes Inc, a startup set up by an Osaka University professor, have been working on treatment drugs and vaccines for the coronavirus.

    By injecting a genetically engineered circular DNA into the body, the envisioned vaccine is expected to stimulate the immune system and make antibodies against the coronavirus.

    "Early results from tests in mice showed increased antibody production and had proven its safety," Yoshimura said, adding that it is possible to produce the DNA vaccine for 200,000 people by the end of this year.

    Meanwhile, Ryuichi Morishita, a professor of clinical gene therapy at Osaka University and founder of the AnGes, said the university will increase the number of people given the vaccine in stages while working to confirm whether antibodies can be produced.

    "We hope the vaccine will become available to the general public between spring and autumn next year," Morishita said.

    Promising candidate

    AnGes' candidate is one of Japan's best hopes for a novel coronavirus vaccine as development is further along than others being produced by firms such as Shionogi& Co and Daiichi Sankyo Co.

    Currently, around 125 vaccines are under development globally, including 10 in human testing, according to the World Health Organization.

    Among them, vaccines from China's CanSino Biologics Inc, US biotechnology company Moderna Inc and British pharmaceutical giant AstraZeneca Plc are already in clinical trials.

    Agencies via Xinhua contributed to this story.

    Most Viewed in 24 Hours
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    97无码免费人妻超| 无码中文字幕日韩专区| 最新版天堂中文在线| 久热中文字幕无码视频| 亚洲欧洲中文日韩久久AV乱码| 久久久久亚洲精品无码网址| 精品久久久无码21p发布| 久久精品人妻中文系列| 日韩爆乳一区二区无码| 中文字幕无码高清晰 | 亚洲Av无码乱码在线znlu| 精品久久亚洲中文无码| 色综合网天天综合色中文男男 | 国产精品无码国模私拍视频 | 久久无码专区国产精品发布| 中文字幕久精品免费视频 | 亚洲欧美综合在线中文| 精品久久无码中文字幕| 无码中文字幕av免费放dvd| 中文字幕日韩人妻不卡一区| 人妻丰满av无码中文字幕| 特级小箩利无码毛片| 911国产免费无码专区| 精品无码一区二区三区爱欲九九| 亚洲欧洲美洲无码精品VA| 中文字幕乱人伦| 免费看无码特级毛片| 中文字幕丰满乱子无码视频| 最近高清中文在线国语字幕5| 人妻少妇精品视中文字幕国语| 色婷婷综合久久久久中文一区二区| 亚洲AV无码之日韩精品| 无码国产亚洲日韩国精品视频一区二区三区 | 中文字幕精品亚洲无线码一区应用| 日韩中文字幕一区| 欧美视频中文字幕| 中文字幕免费高清视频| 欧美精品丝袜久久久中文字幕| 日韩免费在线中文字幕| 在线看片福利无码网址| 无码人妻精品一区二区三区99性|